Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-052528
Filing Date
2025-04-09
Accepted
2025-04-09 16:22:15
Documents
19
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A clpt-20250409.htm   iXBRL DEF 14A 1642661
2 GRAPHIC img242477358_0.jpg GRAPHIC 4535
3 GRAPHIC img242477358_1.jpg GRAPHIC 4074
4 GRAPHIC img242477358_2.jpg GRAPHIC 78718
5 GRAPHIC img242477358_3.jpg GRAPHIC 69528
6 GRAPHIC img242477358_4.jpg GRAPHIC 195680
7 GRAPHIC img242477358_5.jpg GRAPHIC 167624
  Complete submission text file 0000950170-25-052528.txt   3823240

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clpt-20250409.xsd EX-101.SCH 66562
21 EXTRACTED XBRL INSTANCE DOCUMENT clpt-20250409_htm.xml XML 219287
Mailing Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075 9499006833
ClearPoint Neuro, Inc. (Filer) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34822 | Film No.: 25825490
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)